ERBB2 and neoplasm: Overexpression of HER2 can inhibit cell apoptosis, induce angiogenesis and lymphatic angiogenesis, improve cell motility and enhance tumor invasion and metastasis, thus promoting cell growth and proliferation and tumorigenesis.